ZERENEX E/4047831
CAS16951-33-0
ZERENEX E/4047831 (CAS 16951-33-0, C8H7N3OS) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 16951-33-0
- Formula
- C8H7N3OS
- Mol. weight
- 193.23 g/mol
Chemical Specifications
Identifiers
| CAS number | 16951-33-0 |
|---|---|
| Product name | ZERENEX E/4047831 |
| Chinese name | 3-氨基-2-硫代-2,3-二氢喹唑啉-4(1H)-酮盐酸盐 |
| Synonyms | ZERENEX E/4047831; ART-CHEM-BB B020621; AKOS B020621; 3-AMINO-2-MERCAPTO-3H-QUINAZOLIN-4-ONE; 3-AMINO-2-MERCAPTOQUINAZOLIN-4-ONE; 3-amino-2-thioxo-2,3-dihydroquinazolin-4(1H)-one; 4(1H)-quinazolinone, 3-amino-2,3-dihydro-2-thioxo- |
| Molecular formula | C8H7N3OS |
| Molecular weight | 193.23 g/mol |
Physical and chemical properties
| Boiling Point | 178.5 ( ℃ ) |
|---|
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of ZERENEX E/4047831?
The CAS Registry Number of ZERENEX E/4047831 is 16951-33-0. ZERENEX E/4047831 is also known as ZERENEX E/4047831; ART-CHEM-BB B020621; AKOS B020621.
What is the molecular formula and molecular weight of ZERENEX E/4047831?
The molecular formula of ZERENEX E/4047831 is C8H7N3OS, and its molecular weight is 193.23 g/mol.
How can I request a quotation for ZERENEX E/4047831?
Send an inquiry for ZERENEX E/4047831 (CAS 16951-33-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for ZERENEX E/4047831
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.